Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00858585 · ClinicalTrials.gov registry record
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 149
- Enrollment target
NCT00858585 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 149 participants.
The verdict
NCT00858585 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
Study Summary
This study will examine genes in three different tissues and look for similarities and differences between normal cells and cancer cells. The tissues to be studies come from blood, lymph node and cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2009-03 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00858585
The ClinicalTrials.gov registry entry for NCT00858585 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00858585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00858585 about?
NCT00858585 is a clinical study titled "Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study". This study will examine genes in three different tissues and look for similarities and differences between normal cells and cancer cells. The tissues to be studies come from blood, lymph node and cancer.
What is the current status of trial NCT00858585?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2009-03. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT00858585?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.